Stem cells derived from patient placentas reproduce preeclampsia features

A new model developed by researchers at Kumamoto University and collaborators from Tohoku University and Kyushu University could advance research into preeclampsia and other pregnancy complications. The team has developed a robust method for producing human trophoblast stem cells (hTSCs) from late-gestation placentas, opening a new avenue for studying pregnancy complications using patient-derived cells. The work is published in the Proceedings of the National Academy of Sciences.